Results 321 to 330 of about 1,636,979 (366)
Some of the next articles are maybe not open access.
Liquid biopsy enters the clinic — implementation issues and future challenges
Nature Reviews Clinical Oncology, 2021M. Ignatiadis, G. Sledge, S. Jeffrey
semanticscholar +1 more source
MRI to guide biopsies or avoid biopsies?
Current Opinion in Urology, 2018To discuss contemporary data on the value of multiparametric MRI (mpMRI) for guiding the decision to biopsy men at risk for prostate cancer, as well as its utility in active surveillance programs.Although a systematic 12-core biopsy is the current standard of care for men with increased suspicion for prostate cancer, MRI with or without targeted biopsy
Ardeshir R. Rastinehad +2 more
openaire +3 more sources
Biopsy of a biopsy: validation of immunoprofiling in gastric cancer biopsy tissue microarrays
Histopathology, 2002Aims: Tissue microarrays offer an efficient way of examining a large number of tumour cases on a single glass slide. A major concern, however, is tumour heterogeneity. Also, the use of tissue microarrays in biopsy material is unexplored. The purpose of the present study was to assess the possibility and validity of arraying three 0.6‐mm cores per case
Elaine W. Kay +4 more
openaire +3 more sources
Circulating tumor DNA and liquid biopsy in oncology
Nature Cancer, 2020D. Cescon +3 more
semanticscholar +1 more source
Journal of biological regulators and homeostatic agents, 2019
During the early formation and growth of primary tumor (e.g., breast, colon, or prostate cancer), cells are shed from the primary tumor and then circulate through the bloodstream. Many of the major recent advances in targeted therapies have relied on the acquisition of tumor tissue via biopsy before initiation of therapy or after the onset of ...
Candotto, V +5 more
openaire +3 more sources
During the early formation and growth of primary tumor (e.g., breast, colon, or prostate cancer), cells are shed from the primary tumor and then circulate through the bloodstream. Many of the major recent advances in targeted therapies have relied on the acquisition of tumor tissue via biopsy before initiation of therapy or after the onset of ...
Candotto, V +5 more
openaire +3 more sources
JAMA: The Journal of the American Medical Association, 1971
To the Editor.— As a practicing pathologist in a community hospital, I have daily responsibility for interpreting several specimens. In no way are decisions concerning this material avoided; on the contrary, there is constant striving to always make the correct diagnosis. It is indeed the wise man and skillful pathologist" who knows he doesn't know!"
openaire +3 more sources
To the Editor.— As a practicing pathologist in a community hospital, I have daily responsibility for interpreting several specimens. In no way are decisions concerning this material avoided; on the contrary, there is constant striving to always make the correct diagnosis. It is indeed the wise man and skillful pathologist" who knows he doesn't know!"
openaire +3 more sources
To biopsy or not to biopsy? That is the question...
British Journal of Oral and Maxillofacial Surgery, 2016Syedda Abbas +2 more
openaire +2 more sources
Circulating tumor DNA in advanced solid tumors: Clinical relevance and future directions
Ca-A Cancer Journal for Clinicians, 2021Michael L Cheng +2 more
exaly
Molecular imaging in oncology: Current impact and future directions
Ca-A Cancer Journal for Clinicians, 2022Martin G Pomper, Steven P Rowe
exaly